Epidemiology of AIDS-related malignancies an international perspective.

@article{Mbulaiteye2003EpidemiologyOA,
  title={Epidemiology of AIDS-related malignancies an international perspective.},
  author={Sam M. Mbulaiteye and Donald Maxwell Parkin and Charles S. Rabkin},
  journal={Hematology/oncology clinics of North America},
  year={2003},
  volume={17 3},
  pages={
          673-96, v
        }
}
View on PubMed
ph.ucla.edu
117 Citations
Highly Influential Citations
7
Background Citations
50
Results Citations
6

Figures and Tables from this paper

117 Citations

Epidemiology of AIDS-Defining Malignancies
TLDR
With the introduction of highly active antiretroviral therapy (HAART) in 1996, the incidence patterns of these cancers with the exception of cervical cancer dropped significantly, and it is hypothesized that HAART restores immune function and delays progression to AIDS.
AIDS-related malignancies
TLDR
Among the chemotherapeutic agents, pegylated liposomal doxorubicin is an effective therapy for patients with HIV-linked Kaposi's sarcoma.
AIDS-associated cancer in developing nations
TLDR
It is apparent that as the AIDS pandemic proceeds, the burden of neoplastic diseases is increasing in developing nations, and guided prevention and therapeutic interventions suitable for the resource-constrained setting are clearly needed.
Therapy Insight: AIDS-related malignancies—the influence of antiviral therapy on pathogenesis and management
TLDR
The past decade has seen substantial improvements in the treatment of AIDS-related lymphoma, which is attributed partially to a shift in tumor type and more effective regimens and the benefits of administering HAART during therapy must be weighed against possible disadvantages.
Epidemiology of AIDS-Defi ning Malignancies
TLDR
With the introduc- tion of highly active antiretroviral therapy (HAART) in 1996, the incidence patterns of these cancers with the exception of cervical cancer dropped and it is hypothesized that HAART restores immune function and delays progression to AIDS.
Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives.
Anal human papillomavirus and anal squamous cell cancer in people living with HIV/AIDS: implications for southern africa
TLDR
This review explores the possible impact that a rise in the incidence of squamous cell cancer of the anus would have on the region, and strategies that may be employed to identify and counteract this escalation.
A review of the pattern of AIDS defining, HIV associated neoplasms and premalignant lesions diagnosed from 2000–2011 at Kenyatta National Hospital, Kenya
TLDR
Kaposi sarcoma is the leading AIDS defining malignancy in Kenya while invasive squamous cell carcinoma of the conjunctiva is theLeading non-AIDS definingmalignancies and premalignant lesions 10 years pre- and post HAART period.
AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
TLDR
An up-to-date review of the epidemiology, pathogenesis, clinical features, and treatment of various AIDS-related malignancies that are likely to be encountered by an oncologist practicing in the current HAART era is provided.
HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data
TLDR
Current literature is reviewed and merits for integrating cancer research in established HIV programs are explored to obtain timely data about the incidence and burden of cancer in HIV-infected persons in Africa.
...
...

References

SHOWING 1-10 OF 138 REFERENCES
Association of cancer with AIDS-related immunosuppression in adults.
TLDR
Although occurring in overall excess, most non-AIDS-defining cancers do not appear to be influenced by the advancing immunosuppression associated with HIV disease progression.
The epidemiology of acquired immunodeficiency syndrome malignancies.
TLDR
Future efforts need to focus on understanding how the immune perturbation of AIDS results in a limited spectrum of tumors and most urgently on controlling the underlying HIV epidemic.
The epidemiology of acquired immunodeficiency syndrome malignancies.
  • J. Goedert
  • Medicine, Biology
    Seminars in oncology
  • 2000
TLDR
Future efforts need to focus on understanding how the immune perturbation of AIDS results in a limited spectrum of tumors and most urgently on controlling the underlying HIV epidemic.
Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia.
TLDR
HIV infection has restricted effects on cancer incidence that is only partly explained by immunosuppression, and improvements in therapy of HIV infection that prolong survival may lead to further increases in HIV-associated lymphoma.
The epidemiology of AIDS--related neoplasms.
Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis
TLDR
There is reassuring evidence that people with HIV who are only mildly immune deficient may not be at increased risk of non-AIDS-defining cancers, but larger studies with longer periods of follow-up are needed to confirm this.
The spectrum of HIV‐1 related cancers in South Africa
TLDR
In Johannesburg, South Africa, HIV infection was associated with significantly increased risks of Kaposi's sarcoma, non‐Hodgkin lymphoma and cancers of the cervix and the vulva, which were substantially lower than those found in the West.
Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants.
TLDR
It is suggested that current therapies have ameliorated the incidence of Kaposi's sarcoma, but may not have had an equal effect on non-Hodgkin's lymphoma.
AIDS-related cancers in the era of highly active antiretroviral therapy.
TLDR
The relatively low incidence of other cancers in persons with AIDS makes it difficult to gauge the effect of HAART on their incidence, but to date, no significant trends have been reported for specific tumor types or for the overall risk of non-AIDS-related cancers.
Incidence of cervical squamous intraepithelial lesions in HIV-infected women.
TLDR
One in 5 HIV-infected women with no evidence of cervical disease developed biopsy-confirmed SILs within 3 years, highlighting the importance of cervical cancer screening programs in this population.
...
...